Amy D. Wilson, PhD Biogen

Dr. Wilson has been with Biogen since 2011 in Pharmaceutical Operations & Technology, responsible for operational performance improvement.  Prior to joining Biogen, she worked for Wyeth / Pfizer for 10 years, holding a variety of positions supporting manufacturing operations, including production scheduling, new equipment project management, shutdown management, business process improvement, labor and capacity modeling, operational excellence and technical training.  Most recently Dr. Wilson led the team responsible for developing and initiating the implementation of Human Performance risk management practices for all Biogen manufacturing locations.  Today, Dr. Wilson leads Biogen’s Human Performance organizational function responsible for global Human Performance risk management integration and investigation of Quality and Safety high risk events.